q3 earnings per share $1.28.
q3 sales $457 million versus refinitiv ibes estimate of $439.9 million.
qtrly total retail sales increased 34% to $1.2 billion.
sees fy revenue $109 million to $112 million.
q3 sales $14.5 million versus refinitiv ibes estimate of $15.4 billion.
sees q4 adjusted ebitda to be in range of $52 million to $62 million.
qtrly net debt reduction of approximately $40 million.
compname reports q3 revenue up 10% to 15% versus q3 2020.
sees 2021 adjusted earnings per share $25 to $30 million.
sees 2021 capital expenditures of approximately $45 million.
compname reports third quarter 2021 results and announces plan to repurchase up to 35% of its outstanding shares.
q3 sales $14.5 million versus refinitiv ibes estimate of $13.4 billion.
sees fy 2021 revenue $23 million to $27 million.
qtrly shipments were about 4 million cases, down from an average of 4.8 million cases per month in q3 of 2020.
qtrly production of 15.3 million cases, down 4% versus q2 of 2020.
sees 2021 interest expense between $46 million and $48 million, a slight decrease to past expectations.
